Page 96 - TD-4-1
P. 96

Tumor Discovery                                                Identification of a potential KRAS(G12C) inhibitor



                                                               calculations, which confirm the preservation of strong
                                                               binding interactions for both compounds but with distinct
                                                               residue-specific contributions.

                                                               4. Discussion
                                                               In this study, we present potential KRAS(G12C) inhibitors
                                                               identified through a comprehensive approach involving
                                                               covalent  docking-based  virtual  screening  and  MD
                                                               simulations. Our strategy started with a similarity search
                                                               based on the scaffold of Sotorasib, which successfully
                                                               identified 174 molecules from a vast pool of compounds.
                                                               Subsequently, covalent docking-based virtual screening
                                                               was performed, revealing promising KRAS(G12C) protein
                                                               binders, namely, C01, C02a, C02b, and C03. To assess the
                                                               stability of the identified complexes and putative binders,
                                                               MD simulations were employed. Significantly, among the
                                                               candidates, C02b demonstrated exceptional stability as an
                                                               inhibitor targeting the KRAS(G12C) during the 500 ns MD
                                                               simulation, comparable to the reference.
            Figure  9.  PCA dimension plots illustrating the first three principal   In a previous study, it was found that Sotorasib (AMG
            components and displaying the cumulative percentages of variance
            covered by all eigenvectors for the  KRAS(G12C)-C02b structure. The   510) bound to the HIS95 groove and created a connected
            color spectrum, transitioning from blue to red, delineates conformational   network of 25 ligand-protein interactions through van der
            alterations across the simulation. Blue dots signify the initial timesteps,   Waals forces.  This network spanned from the backbone
                                                                         29
            white dots depict intermediate stages, and red dots denote the concluding   of helix 2 (involving HIS95 and TYR96) to the backbone of
            timesteps.
            Abbreviations: PCA: Principal component analysis;  KRAS: Kirsten rat   the flexible switch-II loop. According to the hydrogen bond
            sarcoma viral oncogene homolog.                    analysis performed with VMD and decomposition analysis































                                                                                α
            Figure 10. Flexibility analysis of KRAS(G12C)-C02b structure. The left side presents the RMSF values of C  atoms within the system, while the right side
            displays ribbon representations of the PC1 and PC2 structures. Flexible regions are highlighted with a rainbow color scheme, providing a visual cue to the
            dynamic nature of these segments. Notably, the C12G residue is depicted in black, and the structures were visualized in PyMOL.
            Abbreviations: RMSF: Root mean-square fluctuation; KRAS: Kirsten rat sarcoma viral oncogene homolog; PC1: First principal component; PC2: Second
            principal component.


            Volume 4 Issue 1 (2025)                         88                                doi: 10.36922/td.5163
   91   92   93   94   95   96   97   98   99   100   101